Sex-Related Differences in Cardiac Channelopathies

Sex-related differences in prevalence, clinical presentation, and outcome of cardiac channelopathies are increasingly recognized, despite their autosomal transmission and hence equal genetic predisposition among sexes. In congenital long-QT syndrome, adult women carry a greater risk for Torsades de pointes and sudden cardiac death than do men. In contrast, Brugada syndrome is observed predominantly in adult men, with a considerably higher risk of arrhythmic sudden cardiac death in adult men than in women. In both conditions, the risk for arrhythmias varies with age. Sex-associated differences appear less evident in other cardiac channelopathies, likely a reflection of their rare(r) occurrence and our limited knowledge. In several cardiac channelopathies, sex-specific predictors of outcome have been identified. Together with genetic and environmental factors, sex hormones contribute to the sex-related disparities in cardiac channelopathies through modulation of the expression and function of cardiac ion channels. Despite these insights, essential knowledge gaps exist in the mechanistic understanding of these differences, warranting further investigation. Precise application of the available knowledge may improve the individualized care of patients with cardiac channelopathies. Promoting the reporting of sex-related phenotype and outcome parameters in clinical and experimental studies and advancing research on cardiac channelopathy animal models should translate into improved patient outcomes. This review provides a critical digest of the current evidence for sex-related differences in cardiac channelopathies and emphasizes their clinical implications and remaining gaps requiring further research.

[1]  P. Schwartz,et al.  Mothers with long QT syndrome are at increased risk for fetal death: Findings from a multicenter international study. , 2020, American Journal of Obstetrics and Gynecology.

[2]  A. Wilde,et al.  Caring for the Pregnant Woman with an Inherited Arrhythmia Syndrome. , 2020, Heart rhythm.

[3]  M. Perez,et al.  An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome , 2020, Circulation.

[4]  R. Kovacs,et al.  Effect of Transdermal Testosterone and Oral Progesterone on Drug-Induced QT Interval Lengthening in Older Men: A Randomized, Double-Blind, Placebo-Controlled Crossover-Design Study. , 2019, Circulation.

[5]  D. Roden,et al.  Androgenic Effects on Ventricular Repolarization: A Translational Study From the International Pharmacovigilance Database to iPSC-Cardiomyocytes. , 2019, Circulation.

[6]  J. Skinner,et al.  Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest. , 2019, European heart journal.

[7]  G. Seemann,et al.  Postpartum hormones oxytocin and prolactin cause pro-arrhythmic prolongation of cardiac repolarization in long QT syndrome type 2. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[8]  M. Borggrefe,et al.  Sex-differences in short QT syndrome: A systematic literature review and pooled analysis , 2019, European journal of preventive cardiology.

[9]  A. Wilde,et al.  Response by Wilde and Gollob to Letter Regarding Article, "Reappraisal of Reported Genes for Sudden Arrhythmic Death: Evidence-Based Evaluation of Gene Validity for Brugada Syndrome". , 2019, Circulation.

[10]  J. Healey,et al.  Challenge and Impact of Quinidine Access in Sudden Death Syndromes: A National Experience. , 2019, JACC. Clinical electrophysiology.

[11]  A. Wilde,et al.  Pregnancy in Catecholaminergic Polymorphic Ventricular Tachycardia. , 2019, JACC. Clinical electrophysiology.

[12]  F. Sacher,et al.  Clinical presentation and follow-up of women affected by Brugada syndrome. , 2019, Heart rhythm.

[13]  A. Medeiros-Domingo,et al.  Emerging Implications of Genetic Testing in Inherited Primary Arrhythmia Syndromes , 2019, Cardiology in review.

[14]  P. Schwartz,et al.  Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review. , 2018, Heart rhythm.

[15]  J. Behrends,et al.  Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibility , 2018, European heart journal.

[16]  S. Priori,et al.  Gender differences in patients with Brugada syndrome and arrhythmic events: Data from a survey on arrhythmic events in 678 patients. , 2018, Heart rhythm.

[17]  M. Horie,et al.  Sex‐Dependent Phenotypic Variability of an SCN5A Mutation: Brugada Syndrome and Sick Sinus Syndrome , 2018, Journal of the American Heart Association.

[18]  G. Lip,et al.  Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[19]  A. Moss,et al.  Clinical aspects of the three major genetic forms of long QT syndrome (LQT1, LQT2, LQT3) , 2018, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[20]  J. Skinner,et al.  Long QT molecular autopsy in sudden unexplained death in the young (1-40 years old): Lessons learnt from an eight year experience in New Zealand , 2018, PloS one.

[21]  E. Behr,et al.  The Diagnostic Yield of Brugada Syndrome After Sudden Death With Normal Autopsy. , 2018, Journal of the American College of Cardiology.

[22]  S. Chugh,et al.  Sex Differences in Cardiac Arrhythmias: Clinical and Research Implications , 2018, Circulation. Arrhythmia and electrophysiology.

[23]  S. Viskin,et al.  Long-term flecainide therapy in type 3 long QT syndrome , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[24]  R. Bellazzi,et al.  Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome. , 2017, Journal of the American College of Cardiology.

[25]  S. Priori,et al.  Age of First Arrhythmic Event in Brugada Syndrome: Data From the SABRUS (Survey on Arrhythmic Events in Brugada Syndrome) in 678 Patients , 2017, Circulation. Arrhythmia and electrophysiology.

[26]  K. Hodgkinson,et al.  SEX-INFLUENCED MORTALITY IN THREE WELL-ASCERTAINED FAMILIES WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA CAUSED BY A RYR2 P.R420W MUTATION: THE POWER OF EXTENDED FAMILY HISTORY , 2017 .

[27]  X. Wehrens,et al.  Circadian Variation of Ventricular Arrhythmias in Catecholaminergic Polymorphic Ventricular Tachycardia. , 2017, JACC. Clinical electrophysiology.

[28]  Dan M Roden,et al.  Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial , 2017, JAMA cardiology.

[29]  J. Skinner,et al.  Utility of Post-Mortem Genetic Testing in Cases of Sudden Arrhythmic Death Syndrome , 2017, Journal of the American College of Cardiology.

[30]  W. Shimizu,et al.  Arrhythmia risk and β-blocker therapy in pregnant women with long QT syndrome , 2017, Heart.

[31]  W. Berger,et al.  Post-mortem whole-exome analysis in a large sudden infant death syndrome cohort with a focus on cardiovascular and metabolic genetic diseases , 2017, European Journal of Human Genetics.

[32]  Jørgen K. Kanters,et al.  Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study. , 2016, Circulation.

[33]  J. Skinner,et al.  A Prospective Study of Sudden Cardiac Death among Children and Young Adults. , 2016, The New England journal of medicine.

[34]  S. Priori,et al.  Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3 , 2016, Journal of the American College of Cardiology.

[35]  P. Brugada,et al.  Clinical characterisation and long-term prognosis of women with Brugada syndrome , 2016, Heart.

[36]  S. Tezenas du Montcel,et al.  Asymmetry of parental origin in long QT syndrome: preferential maternal transmission of KCNQ1 variants linked to channel dysfunction , 2015, European Journal of Human Genetics.

[37]  S. Viskin,et al.  Management of Brugada Syndrome: Thirty-Three–Year Experience Using Electrophysiologically Guided Therapy With Class 1A Antiarrhythmic Drugs , 2015, Circulation. Arrhythmia and electrophysiology.

[38]  E. Behr,et al.  Fibrosis, Connexin-43, and Conduction Abnormalities in the Brugada Syndrome , 2015, Journal of the American College of Cardiology.

[39]  Jeffrey M. Vinocur,et al.  Catecholaminergic Polymorphic Ventricular Tachycardia in Children: Analysis of Therapeutic Strategies and Outcomes From an International Multicenter Registry , 2015, Circulation. Arrhythmia and electrophysiology.

[40]  E. Behr,et al.  Clinical Characteristics and Circumstances of Death in the Sudden Arrhythmic Death Syndrome , 2014, Circulation. Arrhythmia and electrophysiology.

[41]  G. Koren,et al.  How do sex hormones modify arrhythmogenesis in long QT syndrome? Sex hormone effects on arrhythmogenic substrate and triggered activity. , 2014, Heart rhythm.

[42]  Guy Salama,et al.  Sex differences in the mechanisms underlying long QT syndrome. , 2014, American journal of physiology. Heart and circulatory physiology.

[43]  S. Priori,et al.  Novel Insight Into the Natural History of Short QT Syndrome , 2014, Journal of the American College of Cardiology.

[44]  P. Brugada,et al.  The clinical significance of pregnancy in Brugada syndrome. , 2014, Revista espanola de cardiologia.

[45]  A. Krahn,et al.  Sudden cardiac death in children and adolescents between 1 and 19 years of age. , 2014, Heart rhythm.

[46]  P. Brugada,et al.  Safe Single‐Dose Administration of Propofol in Patients with Established Brugada Syndrome: A Retrospective Database Analysis , 2013, Pacing and clinical electrophysiology : PACE.

[47]  C. Tracy,et al.  HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. , 2013, Heart rhythm.

[48]  P. Schwartz,et al.  Spectrum and Prevalence of Mutations Involving Brs1-through Brs12-susceptibility Genes in a Cohort of Unrelated Patients Referred for Brugada Syndrome Genetic Testing Implications for Genetic Testing , 2022 .

[49]  Lia Crotti,et al.  Long-QT syndrome: from genetics to management. , 2012, Circulation. Arrhythmia and electrophysiology.

[50]  M. Ackerman,et al.  Potential depot medroxyprogesterone acetate-triggered torsades de pointes in a case of congenital type 2 long QT syndrome. , 2012, Heart rhythm.

[51]  D. Tester,et al.  Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing. , 2012, Mayo Clinic proceedings.

[52]  M. Zehender,et al.  Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. , 2012, Heart rhythm.

[53]  Mike Kirby,et al.  ESC Guidelines on the Management of Cardiovascular Diseases During Pregnancy , 2012 .

[54]  E. Kaufman,et al.  Risk of Recurrent Cardiac Events After Onset of Menopause in Women With Congenital Long-QT Syndrome Types 1 and 2 , 2011, Circulation.

[55]  Tachapong Ngarmukos,et al.  Prevention of Ventricular Fibrillation Episodes in Brugada Syndrome by Catheter Ablation Over the Anterior Right Ventricular Outflow Tract Epicardium , 2011, Circulation.

[56]  A. Shelling,et al.  Prospective, population-based long QT molecular autopsy study of postmortem negative sudden death in 1 to 40 year olds. , 2011, Heart rhythm.

[57]  S. Nattel,et al.  Gender-related differences in ion-channel and transporter subunit expression in non-diseased human hearts. , 2010, Journal of molecular and cellular cardiology.

[58]  M. Kirk,et al.  Pharmacogenomics of anesthetic drugs in transgenic LQT1 and LQT2 rabbits reveal genotype-specific differential effects on cardiac repolarization. , 2008, American journal of physiology. Heart and circulatory physiology.

[59]  D. Tamborero,et al.  Gender differences in clinical manifestations of Brugada syndrome. , 2008, Journal of the American College of Cardiology.

[60]  K. Reinier,et al.  Epidemiology of sudden cardiac death: clinical and research implications. , 2008, Progress in cardiovascular diseases.

[61]  E. Behr,et al.  Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. , 2008, European heart journal.

[62]  M. Kirk,et al.  Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. , 2008, The Journal of clinical investigation.

[63]  Derick R. Peterson,et al.  Risk Factors for Aborted Cardiac Arrest and Sudden Cardiac Death in Children With the Congenital Long-QT Syndrome , 2008, Circulation.

[64]  S. Priori,et al.  Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. , 2007, Heart rhythm.

[65]  Y. Kokubo,et al.  Sex Hormone and Gender Difference—Role of Testosterone on Male Predominance in Brugada Syndrome , 2007, Journal of cardiovascular electrophysiology.

[66]  E. Kaufman,et al.  Long QT syndrome and pregnancy. , 2007, Journal of the American College of Cardiology.

[67]  S. Priori,et al.  Female predominance and transmission distortion in the long-QT syndrome. , 2006, The New England journal of medicine.

[68]  M. Field,et al.  Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome: A Multicenter Study–Part 2 , 2006, Circulation.

[69]  M. O'Neill,et al.  Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome: A Multicenter Study , 2006, Circulation.

[70]  T. Saikawa,et al.  Influence of Menstrual Cycle on QT Interval Dynamics , 2006, Pacing and clinical electrophysiology : PACE.

[71]  A. Wilde,et al.  Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more? , 2005, Cardiovascular research.

[72]  D. Tester,et al.  Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. , 2005, Heart rhythm.

[73]  Borys Surawicz,et al.  Differences between Ventricular Repolarization in Men and Women: Description, Mechanism and Implications , 2003, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[74]  Calum A MacRae,et al.  Risk stratification in the long-QT syndrome. , 2003, The New England journal of medicine.

[75]  Li Zhang,et al.  Modulating effects of age and gender on the clinical course of long QT syndrome by genotype. , 2003, Journal of the American College of Cardiology.

[76]  S. Viskin,et al.  Torsade de Pointes Due to Noncardiac Drugs: Most Patients Have Easily Identifiable Risk Factors , 2003, Medicine.

[77]  M. Rosen,et al.  Testosterone Diminishes the Proarrhythmic Effects of Dofetilide in Normal Female Rabbits , 2002, Circulation.

[78]  Andrew C. Zygmunt,et al.  Ionic and Cellular Basis for the Predominance of the Brugada Syndrome Phenotype in Males , 2002, Circulation.

[79]  Carlo Napolitano,et al.  Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia , 2002, Circulation.

[80]  D. Escande,et al.  Novel SCN5A Mutation Leading Either to Isolated Cardiac Conduction Defect or Brugada Syndrome in a Large French Family , 2001, Circulation.

[81]  P. Arini,et al.  Sex differences on the electrocardiographic pattern of cardiac repolarization: possible role of testosterone. , 2000, American heart journal.

[82]  S. Priori,et al.  Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. , 1998, Circulation.

[83]  P. Kligfield,et al.  QT interval-heart rate relation during exercise in normal men and women: definition by linear regression analysis. , 1996, Journal of the American College of Cardiology.

[84]  S. Priori,et al.  Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. , 1995, Circulation.

[85]  R. Prineas,et al.  Sex differences in the evolution of the electrocardiographic QT interval with age. , 1992, The Canadian journal of cardiology.

[86]  S. Viskin,et al.  Female gender as independent risk factor of torsades de pointes during acquired atrioventricular block. , 2017, Heart rhythm.

[87]  H. Huikuri,et al.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge , 2016, Journal of arrhythmia.

[88]  M. Ackerman,et al.  Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes. , 2013, Translational research : the journal of laboratory and clinical medicine.

[89]  A. Wilde,et al.  Gender differences in the long QT syndrome: effects of beta-adrenoceptor blockade. , 2002, Cardiovascular research.

[90]  A. Moss,et al.  Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. , 1997, Journal of the American College of Cardiology.

[91]  M. Lehmann,et al.  Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. , 1993, JAMA.